We benchmarked this analysis against a study by Namjou et al.30 that identified PPARG, FLI1, SPI1, and CEBPA as liver transcriptional drivers of a set of genes that had significant genome-wide association studies (GWAS) associations with NAFLD. The gene discussed is CEBPA; the disease is metabolic dysfunction-associated steatotic liver disease.